Neuren Pharmaceuticals
NEU.AX
#5122
Rank
NZ$1.98 B
Marketcap
$15.29
Share price
4.80%
Change (1 day)
29.41%
Change (1 year)

Neuren Pharmaceuticals (NEU.AX) - Cash on Hand

Cash on Hand as of December 2023 : NZ$0.25 B

According to Neuren Pharmaceuticals's latest financial reports the company has NZ$0.25 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Neuren Pharmaceuticals - Cash on Hand chart (from 2005 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.24 B471.7%
2022-12-31NZ$43.06 M10.28%
2021-12-31NZ$39.05 M50.69%
2020-12-31NZ$25.91 M79.64%
2019-12-31NZ$14.42 M-41.73%
2018-12-31NZ$24.75 M378.58%
2017-12-31NZ$5.17 M-1.58%
2016-12-31NZ$5.25 M-70.36%
2015-12-31NZ$17.73 M-18.54%
2014-12-31NZ$21.76 M-17.64%
2013-12-31NZ$26.42 M306.81%
2012-12-31NZ$6.49 M-33.97%
2011-12-31NZ$9.83 M402.81%
2010-12-31NZ$1.95 M-53.95%
2009-12-31NZ$4.24 M162.1%
2008-12-31NZ$1.62 M26.09%
2007-12-31NZ$1.28 M-87.85%
2006-12-31NZ$10.58 M-57.57%
2005-12-31NZ$24.94 M7165.52%
2004-12-31NZ$0.34 M
2003-12-31N/A
2002-12-31N/A